Gene · 2621
NIH grants2,018
NIH grants whose papers are about the gene, through NIH's grant-paper links.
281 to 300 of 2,018
Download this page as JSON| Grant | Title | GAS6 papers | Newest fiscal year |
|---|---|---|---|
| R25MD007610 | The CDU-Clinical Research Education and Career Development Program | 1 | 2025 |
| R35CA197568 | Lung Adenocarcinoma: From Genome Alterations to Therapeutic Discovery | 1 | 2025 |
| R35CA197589 | Inducing Proximity: An Emerging Paradigm for New Therapeutic Modalities | 1 | 2025 |
| R35CA210087 | Human natural killer cells: Advancing biology and clinical applications | 1 | 2025 |
| R35CA242379 | Understanding the role of metabolism in cancer | 1 | 2025 |
| R35CA264619 | Metabolic reprogramming of the tumor microenvironment and therapy resistance | 1 | 2025 |
| R35GM122480 | Proteomics and model organism humanization to decode human genetics | 1 | 2025 |
| R35GM131707 | Control of cell proliferation and differentiation by growth pathways | 1 | 2025 |
| R35GM136392 | Molecular and Cellular Dynamics in Mammalian Signal Transduction | 1 | 2025 |
| R35GM141603 | Innate Immune signal transduction specificity in inflammatory disease | 1 | 2025 |
| R35HL150829 | Molecular Regulation of Progressive Pulmonary Fibrosis | 1 | 2025 |
| R35NS111631 | New mechanisms and technologies for understanding post-transcriptional gene regulation in neurons | 1 | 2025 |
| R37CA241486 | Molecular mechanisms underlying lineage plasticity in prostate cancer | 1 | 2025 |
| R37CA245523 | Dissecting the cellular hierarchies of malignant gliomas by single-cell functional genomics | 1 | 2025 |
| R37CA246239 | Potentiating Checkpoint Blockade by Cross-Priming Tumor-Reactive T cells with In Situ Vaccination | 1 | 2025 |
| R37CA266344 | Towards Safer and More Effective CART Cell Therapy Through the Modulation of Myeloid Cytokines | 1 | 2025 |
| R37HD086916 | Exosome Based Placental Maternal Communication | 1 | 2025 |
| R50CA211499 | A proteomics research specialist in developing targeted mass spectrometry methods for quantifying proteins important in cancer | 1 | 2025 |
| R50CA221838 | Advancing Cancer Research through Comprehensive Proteomics and Metabolomics Analyses | 1 | 2025 |
| T15LM011271 | San Diego Biomedical Informatics Education & Research (SABER) | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/grants?page=15